NPX-372

N/A

Report date: 2026/05/06 20:02:28

Base Information

Drug NameNPX-372

Drug Alias NameNPX372NPX-372

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAnti-HERV-H LTR-associating protein 2Anti-CD3

TargetsHERV-H LTR-associating protein 2T cell surface glycoprotein CD3

Therapy Area/IndicationsSolid tumoursNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesNextPoint Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesNextPoint Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A